RT Journal Article
SR Electronic
T1 Updated guidelines for immune thrombocytopenic purpura: Expanded management options
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 664
OP 668
DO 10.3949/ccjm.88a.20201
VO 88
IS 12
A1 Sherwin DeSouza
A1 Dana Angelini
YR 2021
UL http://www.ccjm.org/content/88/12/664.abstract
AB The current American Society of Hematology (ASH) guidelines for the management of patients with immune thrombocytopenic purpura (ITP) are an update to the 2011 guidelines. The updates focus on treating patients with ITP without bleeding in both outpatient and inpatient settings, including those with newly diagnosed, persistent, and chronic ITP refractory to first-line therapy. Recommendations for therapy include corticosteroids, intravenous immunoglobulins, anti-D immunoglobulin, rituximab, splenectomy, and thrombopoietin-receptor agonists, as well as observation.